Impact of megatherapy on survival after relapse from stage 4 neuroblastoma in patients over 1 year of age at diagnosis: a report from the European group for bone marrow transplantation

Ladenstein, Ruth, Lasset, Christine, Hartmann, Olivier, Frappaz, Didier, Garaventa, Alberto, Klingebiel, Thomas, Zucker, Jean Michel, Coze, Carole, Burdach, Stefan, Gadner, Helmut, Paolucci, Paolo, Pearson, Andrew, Pinkerton, Ross, Chauvin, Franck and Philip, Thierry (1993) Impact of megatherapy on survival after relapse from stage 4 neuroblastoma in patients over 1 year of age at diagnosis: a report from the European group for bone marrow transplantation. Journal of Clinical Oncology, 11 12: 2330-2341. doi:10.1200/JCO.1993.11.12.2330

Attached Files (Some files may be inaccessible until you login with your UQ eSpace credentials)
Name Description MIMEType Size Downloads
UQ394509_OA.pdf application/pdf 936.89KB 0

Author Ladenstein, Ruth
Lasset, Christine
Hartmann, Olivier
Frappaz, Didier
Garaventa, Alberto
Klingebiel, Thomas
Zucker, Jean Michel
Coze, Carole
Burdach, Stefan
Gadner, Helmut
Paolucci, Paolo
Pearson, Andrew
Pinkerton, Ross
Chauvin, Franck
Philip, Thierry
Title Impact of megatherapy on survival after relapse from stage 4 neuroblastoma in patients over 1 year of age at diagnosis: a report from the European group for bone marrow transplantation
Journal name Journal of Clinical Oncology   Check publisher's open access policy
ISSN 0732-183X
1527-7755
Publication date 1993-12-01
Sub-type Article (original research)
DOI 10.1200/JCO.1993.11.12.2330
Open Access Status File (Publisher version)
Volume 11
Issue 12
Start page 2330
End page 2341
Total pages 12
Place of publication Alexandria, VA, United States
Publisher American Society of Clinical Oncology
Language eng
Formatted abstract
Purpose: Relapse from stage 4 neuroblastoma usually carries a poor prognosis. A retrospective study using the European Bone Marrow Transplant (EBMT) Solid Tumor Registry was undertaken to define the role of megatherapy (MGT) in relapsed patients.

Patients and Methods: After relapse, 33 boys and 15 girls with previous stage 4 neuroblastoma received intensification by MGT followed by either autologous (n = 42) or allogeneic (n = 6) bone marrow rescue in 11 European institutions. The median age at diagnosis was 47 months (range, 14 to 134) and the median interval from diagnosis to relapse was 16 months (range, 4 to 94). Thirty patients had received only conventional-dose primary treatments (group A), whereas 18 patients had previously received intensification with MGT (group B). The median follow-up time of the total group is 95 months (range, 25 to 185).

Results: The actuarial overall survival rate at 2 years after MGT for relapse is 27% for group A and 0% for group B (P = .02). Three adverse, independent prognostic factors were confirmed by multivariate analysis using the Cox proportional hazards regression model: an interval of less than 12 months between diagnosis and relapse (P < .0001), nonresponding or untreated relapse (P = .0002), and previous MGT during primary treatments (P = .055). None of the other variables analyzed, such as sex, age, bone or bone marrow involvement at diagnosis or at relapse, and type of MGT at relapse, influenced outcome in this patient cohort.

Conclusion: Responding patients who relapse more than 12 months from diagnosis who had not received previous MGT appear to benefit from consolidation MGT. Relapse patients who do not fulfill these criteria gain no advantage from this cost-intensive procedure and should be treated differently.
Q-Index Code C1
Q-Index Status Provisional Code
Institutional Status Non-UQ

Document type: Journal Article
Sub-type: Article (original research)
Collection: School of Medicine Publications
 
Versions
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 33 times in Thomson Reuters Web of Science Article | Citations
Scopus Citation Count Cited 0 times in Scopus Article
Google Scholar Search Google Scholar
Created: Sat, 09 Jul 2016, 04:02:59 EST by System User on behalf of Learning and Research Services (UQ Library)